Anti-nephrolithic potential of SafÅ«f Hajar-al YahÅ«d (Unani Pharmacopeial Formulation) in patients of HasÄ?h al-Kulya (Nephrolithiasis)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with HasÄ?h al-Kulya (nephrolithiasis) as diagnosed by X-Ray/Ultrasound KUB with calculi measuring between 3 to 6 mm with or without any of the following symptoms:
•Bawl al-Dam (Haematuria)
•Siqlâ?? al-Khasira (Heaviness in the Loin)
•Wajaâ?? al-Khasira (Pain in the Loin)
•History of Recurrent UTI
•History of Recurrence of Renal Stone
•Urine showing Calcium Crystaluria

•Patients having acute condition of nephrolithiasis
•Complicated cases of nephrolithiasis requiring surgical intervention
•Patients with hydronephrosis, acute symptoms of UTI or any other renal diseases
•Patients with serum creatinine > 2mg%
•Patients on long-term medications
•Patients with cardiac, pulmonary or hepatic diseases
•Pregnancy and lactation
•Alcohol or drug abuse/ History of alcohol or drug abuse within 6 months prior to baseline

发起方

Central Council for Research in Unani Medicine CCRUM New Delhi